Sarcopenia definitions and their association with fracture risk in older Swedish women.

fracture older adults sarcopenia

Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: England
ID NLM: 8610640

Informations de publication

Date de publication:
09 Feb 2024
Historique:
received: 24 02 2024
revised: 18 01 2024
accepted: 25 01 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

The purpose of this study was to investigate the prevalence of three sarcopenia definitions and their associations with fracture risk in a population of older Swedish women when adjusted for FRAX-based risk factors. 2883 women 77.8 years (mean) old were included. Sarcopenia was defined based on the Sarcopenia Definitions and Outcomes Consortium (SDOC; low handgrip strength and gait speed), revised European Working Group on Sarcopenia in Older People (EWGSOP2; low appendicular lean mass index (ALM, appendicular lean mass/height (kg/m2)), and hand grip strength (kg)) and Asian Working Group for Sarcopenia (AWGS; low ALM, and hand grip strength (kg)) definition. Femoral neck T-score was obtained from dual-energy X-ray absorptiometry. All fractures, confirmed by X-ray or medical record review, were subsequently categorized as major osteoporotic fractures (MOF) and hip fractures. Deaths were verified through regional registers. The total follow-up time was 6.4 ± 1.3 (mean ± SD) years. Cox regression (hazard ratios (HR) and 95% confidence intervals (CI)) analyses were performed adjusted for age, fracture risk assessment (FRAX) variables and femoral neck T-score. Sarcopenia prevalence was 4.5% (n = 129) according to SDOC, 12.5% (n = 360) for EWGSOP2 and 10.3% (n = 296) defined by AWGS. Individuals with sarcopenia defined by SDOC had a higher mortality risk than individuals without sarcopenia (HR: 3.41; 95% CI: 2.51, 4.62) after adjusting for age and FRAX variables. Sarcopenia according to EWGSOP2 and AWGS was not associated with an increased fracture risk after adjusting for age and FRAX variables. Individuals with sarcopenia defined by SDOC had a higher risk for any fractures (HR: 1.48; 95% CI: 1.10, 1.99) and MOF (HR: 1.42; 95% CI: 1.03, 1.98) compared with individuals without sarcopenia after adjusting for clinical risk factors used in FRAX. In conclusion, sarcopenia defined by SDOC, incorporating muscle function/strength, was the only sarcopenia definition associated with fracture risk in older women.

Identifiants

pubmed: 38477811
pii: 7604448
doi: 10.1093/jbmr/zjae026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) [2024]. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.

Auteurs

Anoohya Gandham (A)

Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia.
Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Giulia Gregori (G)

Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.

Lisa Johansson (L)

Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.
Region Västra Götaland, Department of Orthopedics Sahlgrenska University Hospital, Mölndal, Sweden.

Helena Johansson (H)

Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia.
Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.

Nicholas C Harvey (NC)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Liesbeth Vandenput (L)

Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia.

Eugene McCloskey (E)

Centre for Metabolic Bone Diseases, University of Sheffield Medical School, United Kingdom.
MRC Versus Arthritis Centre for Integrated research in Musculoskeletal Ageing, Mellanby Centre for Musculoskeletal Research, University of Sheffield, United Kingdom.

John A Kanis (JA)

Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Henrik Litsne (H)

Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.

Kristian Axelsson (K)

Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.
Region Västra Götaland, Närhälsan Norrmalm, Health Centre, Sweden.

Mattias Lorentzon (M)

Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia.
Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Sweden.
Geriatric Medicine, Institute of Medicine, Sahlgrenska Academy, Sahlgrenska University Hospital, Mölndal, Sweden.

Classifications MeSH